Skip to main content
  1. Sakoda LC, Henderson LM, Rivera MP. Adherence to Lung Cancer Screening: What Exactly Are We Talking About? Ann Am Thorac Soc. 2021 Dec;18(12):1951-1952. doi: 10.1513/AnnalsATS.202106-724VP. PMID: 34380008; PMCID: PMC8641807.
  2. Tailor TD, Chiles C, Yeboah J, Rivera MP, Tong BC, Schwartz FR, Benefield T, Lane LM, Stashko I, Thomas SM, Henderson LM. Cardiovascular Risk in the Lung Cancer Screening Population: A Multicenter Study Evaluating the Association Between Coronary Artery Calcification and Preventive Statin Prescription. J Am Coll Radiol. 2021 Sep;18(9):1258-1266. doi: 10.1016/j.jacr.2021.01.015. Epub 2021 Feb 26. PMID: 33640340; PMCID: PMC8903031.
  3. Clark SD, Reuland DS, Brenner AT, Pignone MP. What is the effect of a decision aid on knowledge, values and preferences for lung cancer screening? An online pre-post study. BMJ Open. 2021 Jul 9;11(7):e045160. doi: 10.1136/bmjopen-2020-045160. PMID: 34244253; PMCID: PMC8273450.
  4. Sakoda LC, Rivera MP, Zhang J, Perera P, Laurent CA, Durham D, Huamani Velasquez R, Lane L, Schwartz A, Quesenberry CP Jr, Minowada G, Henderson LM. Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings. JAMA Netw Open. 2021 Apr 1;4(4):e218559. doi: 10.1001/jamanetworkopen.2021.8559. PMID: 33929519; PMCID: PMC8087957.
  5. Hoffman RM, Reuland DS, Volk RJ. The Centers for Medicare & Medicaid Services Requirement for Shared Decision-making for Lung Cancer Screening. JAMA. 2021 Mar 9;325(10):933-934. doi: 10.1001/jama.2021.1817. PMID: 33687471.
  6. Henderson LM, Rivera MP, Basch E. Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity. JAMA. 2021 Mar 9;325(10):939-941. doi: 10.1001/jama.2020.26422. PMID: 33687453.
  7. Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, Enyioha C, Malo TL, Brenner AT, Armstrong C, Coker-Schwimmer M, Middleton JC, Voisin C, Harris RP. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021 Mar 9;325(10):971-987. doi: 10.1001/jama.2021.0377. PMID: 33687468.
  8. Henderson LM, Durham DD, Tammem├Ągi MC, Benefield T, Marsh MW, Rivera MP. Lung Cancer Screening With Low Dose Computed Tomography in Patients With and Without Prior History of Cancer in the National Lung Screening Trial. J Thorac Oncol. 2021 Jun;16(6):980-989. doi: 10.1016/j.jtho.2021.02.003. Epub 2021 Feb 10. PMID: 33581343; PMCID: PMC8159850.
  9. Henderson LM, Benefield T, Bosemani T, Long JM, Rivera MP. Impact of the COVID-19 Pandemic on Volumes and Disparities in Lung Cancer Screening. Chest. 2021 Jul;160(1):379-382. doi: 10.1016/j.chest.2020.12.033. Epub 2021 Jan 5. PMID: 33417898; PMCID: PMC7784535.
  10. Rivera MP, Katki HA, Tanner NT, Triplette M, Sakoda LC, Wiener RS, Cardarelli R, Carter-Harris L, Crothers K, Fathi JT, Ford ME, Smith R, Winn RA, Wisnivesky JP, Henderson LM, Aldrich MC. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2020 Oct 1;202(7):e95-e112. doi: 10.1164/rccm.202008-3053ST. PMID: 33000953; PMCID: PMC7528802.
  11. Henderson LM, Benefield TS, Bearden SC, Reuland DS, Brenner AT, Goldstein AO, Throneburg A, Rivera MP. Changes in Physician Knowledge, Attitudes, Beliefs, and Practices regarding Lung Cancer Screening. Ann Am Thorac Soc. 2019 Aug;16(8):1065-1069. doi: 10.1513/AnnalsATS.201812-867RL. PMID: 31075047; PMCID: PMC6774750.
  12. Brenner AT, Malo TL, Margolis M, Elston Lafata J, James S, Vu MB, Reuland DS. Evaluating Shared Decision Making for Lung Cancer Screening. JAMA Intern Med. 2018 Oct 1;178(10):1311-1316. doi: 10.1001/jamainternmed.2018.3054. PMID: 30105393; PMCID: PMC6233759.

For a complete list of publications and presentations associated with the Carolina Cancer Screening Initiative, please visit the National Center for Biotechnical Information CCSI Lung Cancer Collection.